Cargando…

Mitochondrial disease disrupts hepatic allostasis and lowers the threshold for immune-mediated liver toxicity

OBJECTIVE: In individuals with mitochondrial disease, respiratory viral infection can result in metabolic decompensation with mitochondrial hepatopathy. Here, we used a mouse model of liver-specific Complex IV deficiency to study hepatic allostasis during respiratory viral infection. METHODS: Mice w...

Descripción completa

Detalles Bibliográficos
Autores principales: Jestin, Maxim, Kapnick, Senta M., Tarasenko, Tatyana N., Burke, Cassidy T., Zerfas, Patricia M., Diaz, Francisca, Vernon, Hilary, Singh, Larry N., Sokol, Ronald J., McGuire, Peter J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167504/
https://www.ncbi.nlm.nih.gov/pubmed/32283081
http://dx.doi.org/10.1016/j.molmet.2020.100981
_version_ 1783523574484566016
author Jestin, Maxim
Kapnick, Senta M.
Tarasenko, Tatyana N.
Burke, Cassidy T.
Zerfas, Patricia M.
Diaz, Francisca
Vernon, Hilary
Singh, Larry N.
Sokol, Ronald J.
McGuire, Peter J.
author_facet Jestin, Maxim
Kapnick, Senta M.
Tarasenko, Tatyana N.
Burke, Cassidy T.
Zerfas, Patricia M.
Diaz, Francisca
Vernon, Hilary
Singh, Larry N.
Sokol, Ronald J.
McGuire, Peter J.
author_sort Jestin, Maxim
collection PubMed
description OBJECTIVE: In individuals with mitochondrial disease, respiratory viral infection can result in metabolic decompensation with mitochondrial hepatopathy. Here, we used a mouse model of liver-specific Complex IV deficiency to study hepatic allostasis during respiratory viral infection. METHODS: Mice with hepatic cytochrome c oxidase deficiency (LivCox10(−/−)) were infected with aerosolized influenza, A/PR/8 (PR8), and euthanized on day five after infection following three days of symptoms. This time course is marked by a peak in inflammatory cytokines and mimics the timing of a common clinical scenario in which caregivers may first attempt to manage the illness at home before seeking medical attention. Metabolic decompensation and mitochondrial hepatopathy in mice were characterized by serum hepatic testing, histology, electron microscopy, biochemistry, metabolomics, and bioenergetic profiling. RESULTS: Following influenza infection, LivCox10(−/−) mice displayed marked liver disease including hepatitis, enlarged mitochondria with cristae loss, and hepatic steatosis. This pathophysiology was associated with viremia. Primary hepatocytes from LivCox10(−/−) mice cocultured with WT Kupffer cells in the presence of PR8 showed enhanced lipid accumulation. Treatment of hepatocytes with recombinant TNFα implicated Kupffer cell-derived TNFα as a precipitant of steatosis in LivCox10(−/−) mice. Eliminating Kupffer cells or blocking TNFα in vivo during influenza infection mitigated the steatosis and mitochondrial morphologic changes. CONCLUSIONS: Taken together, our data shift the narrative of metabolic decompensation in mitochondrial hepatopathy beyond the bioenergetic costs of infection to include an underlying susceptibility to immune-mediated damage. Moreover, our work suggests that immune modulation during metabolic decompensation in mitochondrial disease represents a future viable treatment strategy needing further exploration.
format Online
Article
Text
id pubmed-7167504
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-71675042020-04-22 Mitochondrial disease disrupts hepatic allostasis and lowers the threshold for immune-mediated liver toxicity Jestin, Maxim Kapnick, Senta M. Tarasenko, Tatyana N. Burke, Cassidy T. Zerfas, Patricia M. Diaz, Francisca Vernon, Hilary Singh, Larry N. Sokol, Ronald J. McGuire, Peter J. Mol Metab Brief Communication OBJECTIVE: In individuals with mitochondrial disease, respiratory viral infection can result in metabolic decompensation with mitochondrial hepatopathy. Here, we used a mouse model of liver-specific Complex IV deficiency to study hepatic allostasis during respiratory viral infection. METHODS: Mice with hepatic cytochrome c oxidase deficiency (LivCox10(−/−)) were infected with aerosolized influenza, A/PR/8 (PR8), and euthanized on day five after infection following three days of symptoms. This time course is marked by a peak in inflammatory cytokines and mimics the timing of a common clinical scenario in which caregivers may first attempt to manage the illness at home before seeking medical attention. Metabolic decompensation and mitochondrial hepatopathy in mice were characterized by serum hepatic testing, histology, electron microscopy, biochemistry, metabolomics, and bioenergetic profiling. RESULTS: Following influenza infection, LivCox10(−/−) mice displayed marked liver disease including hepatitis, enlarged mitochondria with cristae loss, and hepatic steatosis. This pathophysiology was associated with viremia. Primary hepatocytes from LivCox10(−/−) mice cocultured with WT Kupffer cells in the presence of PR8 showed enhanced lipid accumulation. Treatment of hepatocytes with recombinant TNFα implicated Kupffer cell-derived TNFα as a precipitant of steatosis in LivCox10(−/−) mice. Eliminating Kupffer cells or blocking TNFα in vivo during influenza infection mitigated the steatosis and mitochondrial morphologic changes. CONCLUSIONS: Taken together, our data shift the narrative of metabolic decompensation in mitochondrial hepatopathy beyond the bioenergetic costs of infection to include an underlying susceptibility to immune-mediated damage. Moreover, our work suggests that immune modulation during metabolic decompensation in mitochondrial disease represents a future viable treatment strategy needing further exploration. Elsevier 2020-03-26 /pmc/articles/PMC7167504/ /pubmed/32283081 http://dx.doi.org/10.1016/j.molmet.2020.100981 Text en Published by Elsevier GmbH. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Brief Communication
Jestin, Maxim
Kapnick, Senta M.
Tarasenko, Tatyana N.
Burke, Cassidy T.
Zerfas, Patricia M.
Diaz, Francisca
Vernon, Hilary
Singh, Larry N.
Sokol, Ronald J.
McGuire, Peter J.
Mitochondrial disease disrupts hepatic allostasis and lowers the threshold for immune-mediated liver toxicity
title Mitochondrial disease disrupts hepatic allostasis and lowers the threshold for immune-mediated liver toxicity
title_full Mitochondrial disease disrupts hepatic allostasis and lowers the threshold for immune-mediated liver toxicity
title_fullStr Mitochondrial disease disrupts hepatic allostasis and lowers the threshold for immune-mediated liver toxicity
title_full_unstemmed Mitochondrial disease disrupts hepatic allostasis and lowers the threshold for immune-mediated liver toxicity
title_short Mitochondrial disease disrupts hepatic allostasis and lowers the threshold for immune-mediated liver toxicity
title_sort mitochondrial disease disrupts hepatic allostasis and lowers the threshold for immune-mediated liver toxicity
topic Brief Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167504/
https://www.ncbi.nlm.nih.gov/pubmed/32283081
http://dx.doi.org/10.1016/j.molmet.2020.100981
work_keys_str_mv AT jestinmaxim mitochondrialdiseasedisruptshepaticallostasisandlowersthethresholdforimmunemediatedlivertoxicity
AT kapnicksentam mitochondrialdiseasedisruptshepaticallostasisandlowersthethresholdforimmunemediatedlivertoxicity
AT tarasenkotatyanan mitochondrialdiseasedisruptshepaticallostasisandlowersthethresholdforimmunemediatedlivertoxicity
AT burkecassidyt mitochondrialdiseasedisruptshepaticallostasisandlowersthethresholdforimmunemediatedlivertoxicity
AT zerfaspatriciam mitochondrialdiseasedisruptshepaticallostasisandlowersthethresholdforimmunemediatedlivertoxicity
AT diazfrancisca mitochondrialdiseasedisruptshepaticallostasisandlowersthethresholdforimmunemediatedlivertoxicity
AT vernonhilary mitochondrialdiseasedisruptshepaticallostasisandlowersthethresholdforimmunemediatedlivertoxicity
AT singhlarryn mitochondrialdiseasedisruptshepaticallostasisandlowersthethresholdforimmunemediatedlivertoxicity
AT sokolronaldj mitochondrialdiseasedisruptshepaticallostasisandlowersthethresholdforimmunemediatedlivertoxicity
AT mcguirepeterj mitochondrialdiseasedisruptshepaticallostasisandlowersthethresholdforimmunemediatedlivertoxicity